Background and aim Coronavirus disease 2019 (COVID-19) is a global pandemic spreading worldwide. Limited studies showed that smokers were at higher risk of having severe complications and higher mortality. This study aims to analyze the possible correlation between adult tobacco smoking prevalence and COVID-19 mortality all over the world. Methods This is a correlation study, we conducted a linear regression to analyse the correlation between smoking prevalence data in adults and COVID-19 Case Fatality Ratio (CFR) in countries with 1000 confirmed COVID-19 cases on May 3, 2020. Results Seventy-five country included with median CFR 3.66%. There are no relationships between adult male or female smoking prevalence with COVID-19 mortality in all over the countries. The multivariate analysis showed p-values of 0.823 and 0.910 for male and female smoking prevalence respectively. However, in lower-middle-income countries (LMIC), there is a positive correlation between the prevalence of adult male smoking with the lethality of COVID-19. Each percentage point increase in adult male smoking prevalence caused a CFR of COVID-19 increase by 0.08% (95% CI 0.00%-0.15%, p=0.041). Conclusions A correlation was found between the prevalence of adult male smoking and the CFR of COVID-19 in lower middle-income countries. Based on these findings, strengthening tobacco control policies is needed to reduce the impact of the COVID-19 pandemic especially in LMIC. Further researches are still needed.
At the onset of the coronavirus disease 2019 (COVID-19) pandemic in Indonesia, surveillance focused on finding and treating symptomatic cases. However, emerging evidence indicated that asymptomatic and pre-symptomatic individuals significantly contributed to viral transmission. This highlights the need for comprehensive surveillance to understand better the actual spread of SARS-CoV-2. Therefore, the aim of this study was to determine the seroprevalence of SARS-CoV-2 antibodies in the general population across Indonesia and identify risk factors associated with infection at the beginning of the pandemic. A cross-sectional survey was conducted across 17 provinces, 69 districts/cities, and 1,020 villages in Indonesia from December 22, 2020, to February 15, 2021. A multistage random sampling technique was employed. Serological testing using enzyme-linked immunosorbent assay (ELISA) was performed to detect anti-SARS-CoV-2. Complex sample analysis, adjusted for weights, was utilized to estimate the national seroprevalence and a generalized linear model with a binomial distribution was applied to identify risk factors. A total of 10,161 individuals were included in the final analysis, with the national seroprevalence being 14.8% (95% confidence interval (CI): 14.2–18.5). The prevalence was higher in females (16.8%; 95%CI: 12.5–22.3), individuals aged 46–59 years (18.6%; 95%CI: 14.2–24.0), and in urban areas (20.1%; 95%CI: 15.0–26.2). The highest prevalence was observed in North Maluku (35.6%; 95%CI: 29.3–42.5). Notably, 54.2% of seropositive individuals were asymptomatic, while 7.5% reported hypertension as a comorbidity. Factors associated with higher seroprevalence were being married (adjusted prevalence ratio (aPR): 1.47; 95%CI: 1.02–2.12), widow (aPR: 1.74, 95%CI: 1.01–3.00), and close contact with confirmed cases (aPR: 2.04; 95%CI: 1.52–2.73). This study revealed a COVID-19 prevalence significantly higher than official estimate in Indonesia, underscoring the need for improved surveillance system to more accurately track disease spread and to inform timely public health responses in the future.
1 January 2025 in GHMJ (Global Health Management Journal)
Background: Obesity place patients at risk of cardiovascular disease (CVD). There may be an inverse relationship between obesity and CVD prognosis-a phenomenon known as the “obesity paradox”. Obese HF patients might have a better prognosis, especially in terms of quality of life (QoL). Aims: The purpose of this study was to examine the QoL of HF patients based on obesity classification. Methods: This cross-sectional study was conducted at the HF clinic of Hasna Medika Cardiovascular Hospital, Cirebon, Indonesia. Samples were HFrEF patients who had received medication at the HF clinic for at least 6 months and the patient must have received optimal guidelines directed medical therapy (GDMT) with at least 3 pillar drugs according to Indonesian heart failure guidelines. Inclusion criteria were HF patients with ejection fraction <40% on echocardiographic examination. Exclusion criteria were HF patients with motor impairments, such as post-stroke, severe osteoarthritis, paralysis, and patients who did not receive optimal GDMT. Results: A total of 40.3% sample were obese, 9.7% were underweight and 67.5% had central obesity. Coronary artery disease (89.6%), smoking (67.5%) and hypertension (49.4%) were the most common comorbidities and risk factors found. About 12.3% of sample experienced rehospitalization 3 times a year. Based on Kansas City Cardiomyopathy Questionnaire (KCCQ)-12, about 3.2% of the sample had poor QoL, 55.8% had good QoL and 9.7% had excellent QoL. HFrEF patients with excellent QoL had a proportion of 66.7% obese and 20% overweight. While there were no obese patients in HFrEF patients with poor QoL. The proportion of HFrEF patients with excellent QoL who had central obesity was 80%. Meanwhile, 65.1% of HFrEF patients with good QoL were obese. Conclusion: Obese HF patients have better QoL outcomes. This phenomenon is called obesity paradox. A good quality of life in HF patients is an important goal of HF management in addition to reducing mortality. Received: 02 December 2024 | Reviewed: 17 December 2024 | Revised: 24 December 2024 | Accepted: 10 January 2025.
Background: COVID-19 might also predispose individuals to elevate blood glucose as the effect of anxiety. Blood glucose level is an important risk factor for the prognosis of disease among diabetes patients. Purpose: This study aimed to assess the effect of Coronavirus-related anxiety with hyperglycemia incidence among type 2 diabetes patients. Methods:A cross-sectional study was conducted among 143 individuals with type 2 diabetes mellitus, from 25 January to 29 February 2021. This study was conducted both online and by assessing archives of medical records using random samples. Results: A total of 143 respondents completed the questionnaire, with 59.44% females and 40.56% males. More than half of the respondents (55.94%) who reported hyperglycemia showed COVID-19 anxiety, and 51.05% of them experienced ≥ 8 years of diabetes. COVID-19 anxiety was associated positively with the risk of hyperglycemia among type 2 diabetes patients (PR>1). Severe worry about the pandemic had the highest risk of hyperglycemia compared to moderate and mild anxiety. This finding is confounded by diabetes duration (PR discrepancy >10% and PR>1 for ≥8 years long-duration). Conclusion: This study suggests a positive association between COVID-19 anxiety and hyperglycemia while the degree of anxiety is associated with an increased risk of hyperglycemia.
Hypertension in women is increased by 30.9% and 26.6% of central obesity in Indonesia. The purpose of this study is to study the relationship of central obesity with hypertension in women aged 18 years and over in Bogor District year 2016. This study used cross sectional design with cox regression analysis. The analysis is used to see how much impact of Central Obesity with hypertension incidence after backward elimination procedure test. Total sample in this study was 525 samples. Results from this study showed an influence of age > 45 years on the association of central obesity with hypertension in women with a PR of 1: 56 (95% CI 1084–2120) and the discovery of potentially confounding variables which is age. The risk of central obesity with hypertension increased after controlled by age as much as PR 1: 52 (95% CI 1: 07 to 2: 16). Central obesity affects the incidence of hypertension in women. It is suggested that all women to increase physical activity, adjusting the diet and conduct regular health checks to maintain the weight to avoid central obesity.